|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2010-8-30
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Only 4 prospective randomized phase 3 trials have been reported for anal cancer. A prognostic factor analysis for anal cancer from a prospective database has been published from only 1 study (N = 110). To confirm and uncover new prognostic factors, we analyzed the prospective database of intergroup RTOG 98-11.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Cancer 2010. (c) 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4007-13
|
|
pubmed:dateRevised |
2011-9-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20564111-Antineoplastic Agents,
pubmed-meshheading:20564111-Anus Neoplasms,
pubmed-meshheading:20564111-Clinical Trials, Phase III as Topic,
pubmed-meshheading:20564111-Databases, Factual,
pubmed-meshheading:20564111-Disease-Free Survival,
pubmed-meshheading:20564111-Female,
pubmed-meshheading:20564111-Humans,
pubmed-meshheading:20564111-Lymphatic Metastasis,
pubmed-meshheading:20564111-Male,
pubmed-meshheading:20564111-Prognosis,
pubmed-meshheading:20564111-Sex Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).
|
|
pubmed:affiliation |
The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. jajani@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
